Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA agrees to review Pfizer’s NDAs for tafamidis

pharmaceutical-technologyJanuary 16, 2019

Tag: FDA , Pfizer , ATTR-CM , tafamidis

PharmaSources Customer Service